Healthcare - Biotechnology - NASDAQ - CA
$ 1.7
-6.08 %
$ 90.6 M
Market Cap
-1.68
P/E
BALANCE SHEET
75.2 M
ASSETS
58.5 M
LIABILITIES
16.8 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Milestone Pharmaceuticals Inc.
| Current Assets | 73 M |
| Cash & Short-Term Investments | 66 M |
| Receivables | 3.85 M |
| Other Current Assets | 3.18 M |
| Non-Current Assets | 2.19 M |
| Long-Term Investments | 0 |
| PP&E | 2.19 M |
| Other Non-Current Assets | 0 |
| Current Liabilities | 7.23 M |
| Accounts Payable | 3.98 M |
| Short-Term Debt | 1.09 M |
| Other Current Liabilities | 2.15 M |
| Non-Current Liabilities | 51.2 M |
| Long-Term Debt | 51.2 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 13.8 | 7.6 | 114.1 | 72.3 | 119.8 | 85.9 | 10.9 |
| Short Term Investments | 52.2 | 56.9 | 0 | 70.0 | 0 | 29 K | 16.0 |
| Receivables | 3.9 | 1.2 | 0.5 | 0.9 | 0.8 | 0.7 | 0.5 |
| Inventory | 0 | (0.3) | (0.4) | (0.7) | (0.6) | 0 | 0 |
| Other Current Assets | 3.2 | 6.0 | 4.3 | 5.4 | 1.8 | 1.4 | 100 K |
| Total Current Assets | 73.0 | 71.8 | 118.9 | 148.7 | 122.5 | 88.1 | 27.6 |
| PP&E | 2.2 | 2.7 | 0.9 | 1.3 | 0.9 | 30 K | 35 K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | (2.7) | (0.9) | (1.3) | (0.9) | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 75.2 | 74.5 | 119.8 | 150.0 | 123.4 | 88.1 | 27.6 |
| LIABILITIES | |||||||
| Accounts Payable | 4.0 | 2.3 | 4.4 | 4.6 | 4.4 | 2.6 | 4 K |
| Short Term Debt | 1.1 | 1.0 | 0.4 | 0.5 | 0.7 | 0 | 0 |
| Other Current Liabilities | 2.2 | 2.9 | 1.9 | 1.0 | 3.3 | 1.9 | 1.6 |
| Total Current Liabilities | 7.2 | 6.1 | 6.8 | 6.2 | 8.3 | 4.5 | 1.6 |
| Long Term Debt | 51.2 | 2.0 | 0.5 | 0.7 | 0.2 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 138.8 | 59.1 |
| Total Liabilities | 58.5 | 8.1 | 7.2 | 6.9 | 8.5 | 143.3 | 60.7 |
| EQUITY | |||||||
| Common Stock | 260.5 | 273.9 | 251.9 | 251.7 | 226.2 | 2.0 | 1.2 |
| Retained Earnings | (326.0) | (266.3) | (206.3) | (163.5) | (113.5) | (58.3) | (35.1) |
| Other Accumulative Comprehensive Income/Loss | 48.5 | 34.4 | (1.6) | (1.6) | (1.6) | (1.6) | (1.6) |
| Total Equity | 16.8 | 66.3 | 112.6 | 143.1 | 114.9 | (55.2) | (33.1) |
| Total Liabilities and Equity | 75.2 | 74.5 | 119.8 | 150.0 | 123.4 | 88.1 | 27.6 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 43.0 | 42.5 | 41.8 | 29.3 | 15.8 | 23.6 | 23.6 |